Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation
Crossref DOI link: https://doi.org/10.1186/s12885-016-2341-y
Published Online: 2016-05-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kucerova, Lucia
Demkova, Lucia
Skolekova, Svetlana
Bohovic, Roman
Matuskova, Miroslava
Funding for this research was provided by:
SRDA (APVV-0230-11, APVV-0052-12)
Slovak Academy of Sciences VEGA (2/0087/15, 2/0071/13)